TLX EBIT

TLX Annual EBIT

$10.77 M
+$74.81 M+116.82%

01 December 2023

TLX EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLX EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+116.8%--
3 y3 years+133.3%--
5 y5 years+191.9%--

TLX EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+116.8%
5 y5-yearat high+116.8%
alltimeall timeat high+116.8%

Telix Pharmaceuticals Limited EBIT History

DateAnnualQuarterlyTTM
Dec 2023
$10.77 M(-116.8%)
-
-
Dec 2022
-$64.04 M(+13.3%)
-
-
Dec 2021
-$56.51 M(+74.9%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
-$32.31 M(+61.9%)
-
-
Dec 2019
-$19.96 M(+70.4%)
-
-
Dec 2018
-$11.71 M(+140.1%)
-
-
Dec 2017
-$4.88 M
-
-

FAQ

  • What is Telix Pharmaceuticals Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Telix Pharmaceuticals Limited?
  • What is Telix Pharmaceuticals Limited annual EBIT year-on-year change?

What is Telix Pharmaceuticals Limited annual earnings before interest & taxes?

The current annual EBIT of TLX is $10.77 M

What is the all time high annual EBIT for Telix Pharmaceuticals Limited?

Telix Pharmaceuticals Limited all-time high annual earnings before interest & taxes is $15.25 M

What is Telix Pharmaceuticals Limited annual EBIT year-on-year change?

Over the past year, TLX annual earnings before interest & taxes has changed by +$74.81 M (+116.82%)